Clinical Researchers Aim to Improve Breast Cancer Outcomes Through Sustainable and Effective Weight Loss in the FITWISE study
Rutgers Cancer InstituteLearn more about FITWISE at RWJBarnabas Health and Rutgers Cancer Institute, an innovative clinical trial aiming to induce sustainable weight loss, improve cardiometabolic health and potentially reduce cancer recurrence during the survivorship years of patients with early-stage hormone receptor positive/Her 2 negative (HR+/Her2-) breast cancer.